Key facts
- This page summarizes Heidi Henson's Form 4 filing for LISATA THERAPEUTICS, INC. (LSTA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Jan 2026, 16:05.
Heidi Henson - 09 Jan 2026 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)
- Reporting relationship
- Director
- Issuer ticker
- LSTA
- Reported as of
- 09 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2026, 16:05:23 UTC
- Prior SEC filing
- 06 Jun 2025
- Next SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- James Nisco, Attorney-in-fact for Heidi Henson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Heidi Henson filed Form 4 for LISATA THERAPEUTICS, INC. (LSTA) on 13 Jan 2026.
Change
- Previous filing in this sequence was filed on 06 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001283301
Primary reporting owner
HENSON HEIDI
- Relationship
- Director
- Address
- C/O LISATA THERAPEUTICS, INC., 110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE
- Signature
- James Nisco, Attorney-in-fact for Heidi Henson
- Signature date
- 13 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LSTA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +30,456
- Change %
- +55%
- Price
- $0.000000
- Shares after
- 85,725
- Date
- 09 Jan 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027.
Footnote F2
Includes 30,456 unvested restricted stock units.